Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
1.99
Dollar change
-0.05
Percentage change
-2.45
%
Index- P/E- EPS (ttm)-4.34 Insider Own24.13% Shs Outstand47.69M Perf Week-14.96%
Market Cap95.22M Forward P/E- EPS next Y-0.49 Insider Trans0.00% Shs Float36.31M Perf Month-5.24%
Income-77.08M PEG- EPS next Q-0.30 Inst Own19.17% Short Float0.80% Perf Quarter-35.60%
Sales39.40M P/S2.42 EPS this Y62.36% Inst Trans-8.36% Short Ratio0.29 Perf Half Y-56.83%
Book/sh-1.48 P/B- EPS next Y44.04% ROA-91.12% Short Interest0.29M Perf Year-80.79%
Cash/sh0.79 P/C2.50 EPS next 5Y- ROE-972.83% 52W Range1.56 - 10.94 Perf YTD-46.79%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-81.81% Beta-0.14
Dividend TTM- Quick Ratio0.90 Sales past 5Y-5.58% Gross Margin76.34% 52W Low27.56% ATR (14)0.35
Dividend Ex-Date- Current Ratio0.99 EPS Y/Y TTM-1544.19% Oper. Margin-174.51% RSI (14)42.79 Volatility13.38% 18.21%
Employees252 Debt/Eq- Sales Y/Y TTM- Profit Margin-195.67% Recom1.00 Target Price5.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-3253.12% Payout- Rel Volume0.11 Prev Close2.04
Sales Surprise0.43% EPS Surprise21.23% Sales Q/Q- EarningsMar 21 BMO Avg Volume1.01M Price1.99
SMA20-5.93% SMA50-21.73% SMA200-53.99% Trades Volume106,718 Change-2.45%
Date Action Analyst Rating Change Price Target Change
Feb-09-24Initiated Jefferies Buy $5
Apr-17-24 08:31AM
Apr-04-24 08:00AM
Mar-21-24 12:53PM
08:00AM
Mar-13-24 08:30AM
08:00AM Loading…
Mar-12-24 08:00AM
Mar-04-24 08:30AM
Feb-20-24 04:05PM
Feb-08-24 08:30AM
Jan-29-24 08:00AM
Jan-23-24 09:04AM
08:15AM
Jan-17-24 08:00AM
Jan-11-24 08:00AM
Jan-08-24 08:00AM
08:00AM Loading…
Jan-05-24 08:00AM
Jan-02-24 08:00AM
Nov-13-23 08:00AM
Nov-06-23 04:05PM
08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-18-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-04-23 01:33PM
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chardon BenoitChief Commercial OfficerDec 12 '23Option Exercise1.19165,539197,562199,183Dec 14 07:17 PM